Invention Grant
- Patent Title: Hepatitis C virus inhibitors
- Patent Title (中): 丙型肝炎病毒抑制剂
-
Application No.: US12816148Application Date: 2010-06-15
-
Publication No.: US08221737B2Publication Date: 2012-07-17
- Inventor: Yat Sun Or , Xiaowen Peng , Lu Ying , Ce Wang , Yao-Ling Qiu
- Applicant: Yat Sun Or , Xiaowen Peng , Lu Ying , Ce Wang , Yao-Ling Qiu
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: A61P29/00
- IPC: A61P29/00 ; A61P31/14 ; A61P37/02 ; A61P31/12 ; A61K38/21 ; A61K31/4184 ; A61K31/675 ; A61K31/41 ; A61K31/4192 ; A61K31/4439 ; A61K31/423 ; A61K31/5377 ; A61K31/496 ; A61K31/427 ; A61K31/422 ; A61K31/4196 ; A61K31/50631 ; A61K31/424531 ; A61K31/43331 ; A61K31/470931 ; A61K31/51931 ; A61K31/5231
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20100316607A1 HEPATITIS C VIRUS INHIBITORS Public/Granted day:2010-12-16
Information query
